OTC : MEDOF

Medios AG

$50 USD

$0 (0.0%)

Volume
2K
Average Volume
1.6K
Market Capitalization
$1.28B
P/E Ratio
20.40
Dividend Yield
0.00%
Price Target
Year High
$50.00
Year Low
$13.64
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.92
Company Overview

OTC

Thomas Meier

Medical - Distribution

Healthcare

MEDOF

993

DE

USD

https://medios.group

49 30 232 5668 00

N/A

N/A

Liquidity Metrics

0.39

1.92

1.47

0.49

0.00

Sales & Valuation

$2.08B

0.13

0.53

5.77

2.02

Profitability

$0.61

$15.36M

0.66%

1.27%

2.69%

1.52%

P/E Metrics

20.40

-3.01

-3.01

Analyst Price Target & Rating

Neutral

3/5

1 Analysts

%

Financial Health Scores

4.51

6/9

$175.76M

$918.23M

$398.53M

$44.72M

Key Metrics (TTM)

$390.4M

0.18

4.78

1.92

2.69%

2.99%

5.17%

17.67%

$16.47

28 days

Company Executives
Name Title
Claudia Nickolaus Head of Investor & Public Relations
Christoph Prusseit Chief Business Officer of Germany & Member of Executive Board
Stefan Bauerreis CFO & Member of the Executive Board
Thomas Meier CEO & Member of Executive Board
Constantijn van Rietschoten Chief Business Officer of International and Member of Executive Board
Poll Results

No votes yet today — be the first to share your view!

About Medios AG (OTC:MEDOF) Stock

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, i ... nfectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.

Frequently Asked Questions

What is the current Medios AG (MEDOF) stock price?

Medios AG(OTC:MEDOF) stock price is $50 in the last trading session. During the trading session, MEDOF stock reached the peak price of $50 while $13.64 was the lowest point it dropped to. The percentage change in MEDOF stock occurred in the recent session was 0.0% while the dollar amount for the price change in MEDOF stock was $0.

MEDOF's industry and sector of operation?

The OTC listed MEDOF is part of Medical - Distribution industry that operates in the broader Healthcare sector.

Who are the executives of MEDOF?

Claudia Nickolaus | Head of Investor & Public Relations
Christoph Prusseit | Chief Business Officer of Germany & Member of Executive Board
Stefan Bauerreis | CFO & Member of the Executive Board
Thomas Meier | CEO & Member of Executive Board
Constantijn van Rietschoten | Chief Business Officer of International and Member of Executive Board

How many employees does MEDOF have?

Number of MEDOF employees currently stands at 993. MEDOF operates from Heidestrasse 9, Berlin, 10557, DE.

Link for MEDOF official website?

Official Website of MEDOF is: https://medios.group

How do I contact MEDOF?

MEDOF could be contacted at phone #49 30 232 5668 00 and can also be accessed through its website. MEDOF operates from Heidestrasse 9, Berlin, 10557, DE.

How many shares of MEDOF are traded daily?

The average number of MEDOF shares traded daily for last 3 months was 1.6K.

What is the market cap of MEDOF currently?

The market value of MEDOF currently stands at $1.28B with its latest stock price at $50